🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

359 results for “vaccine” Clear

  1. Influenza vaccine GSK2321138A

    GlaxoSmithKline

    Influenza

    phase 3 mab completed

    1 trial

  2. Investigational live attenuated mumps vaccine

    Sinovac Research and Development Co.,

    Mumps

    phase 3 mab completed

    2 trials

  3. Investigational tetanus vaccine, adsorbed

    Sinovac Research and Development Co.,

    Tetanus

    phase 3 mab completed

    1 trial

  4. Japanese encephalitis vaccine

    Sanofi Pasteur

    Japanese Encephalitis

    phase 3 mab completed

    1 trial

  5. Live Attenuated Respiratory Syncytial Virus (RSV) ∆NS2/∆1313/I1314L vaccine, Matched

    Sanofi-aventis Healthcare Pty Ltd

    Virus diseases

    phase 3 small molecule active

    1 trial

  6. Live attenuated Japanese encephalitis chimeric virus vaccine

    Sanofi Pasteur

    Japanese Encephalitis

    phase 3 mab completed

    1 trial

  7. Live attenuated SA 14-14-2 vaccine

    Repatha

    Encephalitis, Japanese B

    phase 3 mab completed

    1 trial

  8. Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

    Sinovac Research and Development Co.,

    Varicella

    phase 3 mab active

    1 trial

  9. Live-Attenuated influenza Vaccine(LAIV)

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    phase 3 mab completed

    1 trial

  10. MCV-ACYW135 Vaccine Group

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Meningitis

    phase 3 mab completed

    1 trial

  11. MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)

    Seqirus (Australia) Pty Ltd

    Influenza

    phase 3 mab completed

    1 trial

  12. Medium-dosage COVID-19 Vaccine,Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab terminated

    1 trial

  13. MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine

    Sanofi Pasteur

    Meningococcal infection

    phase 3 small molecule active

    1 trial

  14. Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine

    Sanofi Pasteur

    Meningococcal Infection

    phase 3 mab completed

    1 trial

  15. Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine

    Sanofi Pasteur

    Meningococcal Immunization

    phase 3 mab completed

    1 trial

  16. Meningococcal vaccine GSK134612

    GlaxoSmithKline

    Infections, Meningococcal

    phase 3 mab completed

    2 trials

  17. Mevac-A vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    HAV

    phase 3 mab completed

    1 trial

  18. Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups A, C, W-135 and Y conjugate vaccine, Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups A, C, W-135 and Y conjugate vaccine, MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine, Nimenrix powder and solvent for solution for injection in pre-filled syringe Meningococcal groups A, C, W-135 and Y conjugate vaccine, Nimenrix powder and s

    Sanofi Pasteur

    Healthy volunteers (Meningococcal infection)

    phase 3 small molecule active

    1 trial

  19. Oka strain varicella attenuated live vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chickenpox Vaccines

    phase 3 mab completed

    1 trial

  20. Omicron COVID-19 Vaccine (Vero Cell), Inactivated

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 3 mab active

    2 trials

  21. PCV21 vaccine

    Sanofi Pasteur

    Pneumococcal Immunization

    phase 3 mab active

    1 trial

  22. PREVNAR 20 ®, Pneumococcal Conjugate Vaccine (PCV)

    Sanofi-aventis Healthcare Pty Ltd

    Pneumococcal immunisation

    phase 3 small molecule active

    1 trial

  23. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Biotech Pharmaceutical Co.,

    Influenza

    phase 3 mab active

    1 trial

  24. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Sinovac Research and Development Co.,

    Influenza

    phase 3 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources